Comparing combination and single-agent therapy for the treatment of pemphigus: a retrospective cohort study

Published: 27 January 2025| Version 1 | DOI: 10.17632/3dngby9nhx.1
Contributor:
Soahum Bagchi

Description

Supplementary data (figure and tables) to the reterospective cohort study: - Address issues in clinical practice – Mono vs multi-modal therapy is given in terms of multiple therapeutic agents in pemphigus vulgaris and foliaceous.

Files

Institutions

  • Beth Israel Deaconess Medical Center
  • Harvard Medical School
  • Massachusetts General Hospital

Categories

Dermatology, Rituximab, Mycophenolate Mofetil, Combination Therapy, Monotherapy, Pemphigus

Licence